We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current PGEN market cap is 408.72M. The company's latest EPS is USD -0.4293 and P/E is -3.21.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.23M | 1.07M | 717k | 953k | 1.19M |
| Operating Income | -33.78M | -24.41M | -27.93M | -21.26M | -29.11M |
| Net Income | -33.06M | -23.74M | -58.79M | -23.98M | -19.73M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 103.18M | 103.87M | 26.91M | 6.23M | 3.93M |
| Operating Income | -87.74M | -79.32M | -74.86M | -99.31M | -102.71M |
| Net Income | -170.52M | -92.17M | 28.32M | -95.9M | -126.24M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 151.04M | 134.85M | 73.16M | 83.47M | 145.27M |
| Total Liabilities | 32.55M | 37.83M | 29.99M | 28.1M | 78.54M |
| Total Equity | 118.5M | 97.02M | 43.17M | 55.38M | 38.51M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 314.59M | 359.86M | 215.98M | 151.04M | 145.27M |
| Total Liabilities | 247.41M | 252.51M | 89.72M | 32.55M | 78.54M |
| Total Equity | 67.17M | 107.35M | 126.26M | 118.5M | 38.51M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.93M | -14.09M | -37.2M | -59.93M | -68.17M |
| Investing | -3.09M | 24.05M | 39M | 44.65M | -20.71M |
| Financing | 29.59M | N/A | 52k | 32.18M | 110.58M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -77.02M | -55.77M | -65.05M | -66.93M | -68.17M |
| Investing | 27.78M | -74.54M | 226.42M | -3.09M | -20.71M |
| Financing | 32.71M | 121.19M | -155.29M | 29.59M | 110.58M |
| Market Cap | 408.72M |
| Price to Earnings Ratio | -3.21 |
| Price to Sales Ratio | 103.76 |
| Price to Cash Ratio | 13.75 |
| Price to Book Ratio | 6.08 |
| Dividend Yield | - |
| Shares Outstanding | 294.04M |
| Average Volume (1 week) | 1.19M |
| Average Volume (1 Month) | 1.48M |
| 52 Week Change | 0.00% |
| 52 Week High | 2.17 |
| 52 Week Low | 0.6513 |
| Spread (Intraday) | 0.24 (15.09%) |
| Company Name | Precigen Inc |
| Address |
4701 cox road glen allen, virginia 23060 |
| Website | https://www.dna.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
